title: Immunosuppression in pancreas transplantation: the Euro SPK trials and beyond.
abstract: The Immunosuppression in Pancreas Transplantation was historically based on the fact that the pancreas is an extremely immunogenic organ. Quadruple drug therapy with polyclonal or monoclonal antibodies induction was the mainstay therapy since the introduction of Cyclosporine A. In the modern era of Immunosuppression, Mycophenolate Mofetil replaced Azathioprine while Tacrolimus-another potent calcineurin inhibitor-had-and still has-a difficult challenge to replaced Cyclosporine A, due to its potential diabetogenic effect. Thanks to the first two EuroSPK studies which prospectively tried to answer several questions in that field. But, the future challenge will be in understanding the impact of innate immunity and ischemic reperfusion injuries on the long-term graft function. Hopefully, new drugs will be available and tested to block unspecific deleterious reactions to attenuate the proinflammatory response. It will be the aim of the third Euro SPK Study.
authors.affiliation: Euro SPK Office, Liege, Belgium.
authors.forename: J
authors.initials: J
authors.lastname: Malaise
authors.forename: A
authors.initials: A
authors.lastname: De Roover
authors.forename: J P
authors.initials: JP
authors.lastname: Squifflet
authors.forename: W
authors.initials: W
authors.lastname: Land
authors.forename: P
authors.initials: P
authors.lastname: Neuhaus
authors.forename: J
authors.initials: J
authors.lastname: Pratschke
authors.forename: A
authors.initials: A
authors.lastname: Kahl
authors.forename: A
authors.initials: A
authors.lastname: Pascher
authors.forename: S
authors.initials: S
authors.lastname: Boas-Knoop
authors.forename: H
authors.initials: H
authors.lastname: Arbogast
authors.forename: J
authors.initials: J
authors.lastname: Hoffmann
authors.forename: W D
authors.initials: WD
authors.lastname: Illner
authors.lastname: Seissler
authors.lastname: Schlamp
authors.lastname: Viebahn
authors.lastname: Wunsch
authors.lastname: Hajt
authors.forename: E
authors.initials: E
authors.lastname: Klar
authors.forename: W
authors.initials: W
authors.lastname: Scharek
authors.lastname: Hopt
authors.forename: P
authors.initials: P
authors.lastname: Pisarski
authors.forename: O
authors.initials: O
authors.lastname: Drognitz
authors.forename: C
authors.initials: C
authors.lastname: Thurow
authors.forename: K
authors.initials: K
authors.lastname: Dette
authors.forename: W O
authors.initials: WO
authors.lastname: Bechstein
authors.forename: G
authors.initials: G
authors.lastname: Woeste
authors.forename: J
authors.initials: J
authors.lastname: Klempnauer
authors.forename: T
authors.initials: T
authors.lastname: Becker
authors.lastname: Lück
authors.lastname: Neipp
authors.forename: A
authors.initials: A
authors.lastname: Königsrainer
authors.forename: W
authors.initials: W
authors.lastname: Steurer
authors.forename: R
authors.initials: R
authors.lastname: Margreiter
authors.lastname: Mark
authors.lastname: Bonatti
authors.forename: F
authors.initials: F
authors.lastname: Saudek
authors.forename: P
authors.initials: P
authors.lastname: Boucek
authors.forename: M
authors.initials: M
authors.lastname: Adamec
authors.forename: T
authors.initials: T
authors.lastname: Havrdova
authors.forename: R
authors.initials: R
authors.lastname: Koznarova
authors.forename: Y
authors.initials: Y
authors.lastname: Vanrenterghem
authors.forename: J
authors.initials: J
authors.lastname: Pirenne
authors.forename: B
authors.initials: B
authors.lastname: Maes
authors.forename: D
authors.initials: D
authors.lastname: Kuypers
authors.forename: W
authors.initials: W
authors.lastname: Coosemans
authors.forename: P
authors.initials: P
authors.lastname: Evenepoel
authors.forename: D
authors.initials: D
authors.lastname: van Ophem
authors.forename: V
authors.initials: V
authors.lastname: Marcelis
authors.lastname: van Vlem
authors.lastname: Peeters
authors.lastname: de Hemptinne
authors.lastname: de Roose
authors.forename: L
authors.initials: L
authors.lastname: Fernandez-Cruz
authors.forename: M J
authors.initials: MJ
authors.lastname: Ricart
authors.forename: R
authors.initials: R
authors.lastname: Nakache
authors.forename: P
authors.initials: P
authors.lastname: Morel
authors.forename: T
authors.initials: T
authors.lastname: Berney
authors.forename: S
authors.initials: S
authors.lastname: Demuylder
mesh_terms: D001530:Belgium; D002097:C-Reactive Protein / Q000032:analysis; D002986:Clinical Trials as Topic; D006084:Graft Rejection / Q000517:prevention & control; D006801:Humans; D007165:Immunosuppression Therapy; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D016035:Pancreas Transplantation / Q000276:immunology*
chemical_list: D007166:Immunosuppressive Agents; D002097:C-Reactive Protein